<DOC>
	<DOCNO>NCT01216384</DOCNO>
	<brief_summary>The primary objective current study investigate safety tolerability BI 671800 HEA healthy Chinese male volunteer follow single oral administration , healthy Japanese male volunteer follow single oral administration multiple administration .</brief_summary>
	<brief_title>Single Rising Dose ( SRD ) , Multiple Rising Dose ( MRD ) Study BI 671800 Healthy Asian Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy 2 . Chinese ethnicity single rise dose ( SRD ) part , Japanese Ethnicity multiple rise dose ( MRD ) part . 3 . Age &gt; = 20 age = &lt; 50 4 . Body Mass Index ( BMI ) &gt; =18.5 BMI = &lt; 25 kg/m2 5 . Signed date write informed consent prior admission study accordance GCP local legislation Exclusion criterion : 1 . Any finding medical examination ( include blood pressure ( BP ) , pulse rate ( PR ) electrocardiogram ( ECG ) ) deviate normal clinical relevance accord investigator medical judgement 2 . Any evidence clinically relevant concomitant disease 3 . Intake drug long half life ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>